DE60226251D1 - Verbesserung der transfektion von dna in die leber - Google Patents

Verbesserung der transfektion von dna in die leber

Info

Publication number
DE60226251D1
DE60226251D1 DE60226251T DE60226251T DE60226251D1 DE 60226251 D1 DE60226251 D1 DE 60226251D1 DE 60226251 T DE60226251 T DE 60226251T DE 60226251 T DE60226251 T DE 60226251T DE 60226251 D1 DE60226251 D1 DE 60226251D1
Authority
DE
Germany
Prior art keywords
dna
transfection
liver
improving
dna encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60226251T
Other languages
English (en)
Other versions
DE60226251T2 (de
Inventor
Michael H Davidson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE60226251D1 publication Critical patent/DE60226251D1/de
Application granted granted Critical
Publication of DE60226251T2 publication Critical patent/DE60226251T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0083—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60226251T 2001-07-10 2002-07-10 Verbesserung der transfektion von dna in die leber Expired - Lifetime DE60226251T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30378401P 2001-07-10 2001-07-10
US303784P 2001-07-10
PCT/US2002/021620 WO2003006608A2 (en) 2001-07-10 2002-07-10 Enhancement of transfection of dna into the liver

Publications (2)

Publication Number Publication Date
DE60226251D1 true DE60226251D1 (de) 2008-06-05
DE60226251T2 DE60226251T2 (de) 2009-05-14

Family

ID=23173680

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60226251T Expired - Lifetime DE60226251T2 (de) 2001-07-10 2002-07-10 Verbesserung der transfektion von dna in die leber

Country Status (8)

Country Link
US (2) US7211248B2 (de)
EP (1) EP1420643B1 (de)
JP (1) JP4426288B2 (de)
AT (1) ATE392812T1 (de)
AU (1) AU2002320348B2 (de)
CA (1) CA2452471C (de)
DE (1) DE60226251T2 (de)
WO (1) WO2003006608A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243696B (en) * 2003-10-15 2005-11-21 Der-Yang Tien System for introducing macromolecule substance into living target cell
US20110071381A1 (en) * 2003-10-15 2011-03-24 Robert Tien Method and system for leading macromolecule substances into living target cells
US8505544B2 (en) * 2005-05-31 2013-08-13 The Board Of Trustees Of The Leland Stanford Junior University Optically-implemented microsurgery system and approach
EP2123256A1 (de) 2008-05-19 2009-11-25 Ruhr-Universität Bochum Perfluorkohlenstoff-Nanoemulsionen mit Endozytose-verbessernder Oberfläche für die Genübertragung
WO2011022672A1 (en) * 2009-08-20 2011-02-24 Allegheny-Singer Research Institute Ultrasound-assisted gene transfer to salivary glands
US9101745B2 (en) * 2013-03-14 2015-08-11 Sonogene Llc Sonochemical induction of ABCA1 expression and compositions therefor
US10052394B2 (en) 2014-11-21 2018-08-21 General Electric Company Microbubble tether for diagnostic and therapeutic applications

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8721015D0 (en) * 1987-09-07 1987-10-14 Amersham Int Plc Modifying living cells
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
JPH03297475A (ja) * 1990-04-16 1991-12-27 Ken Ishihara 共振音波により薬物の放出を制御する方法
ATE146073T1 (de) * 1991-03-22 1996-12-15 Katsuro Tachibana Verstärker zur ultraschalltherapie von erkrankungen sowie diesen enthaltende flüssige arzneimittelzusammensetzungen
CN1056124A (zh) 1991-06-05 1991-11-13 清华大学 高效超声波基因导入方法
WO1994010322A1 (en) * 1992-10-29 1994-05-11 Board Of Regents, The University Of Texas System Adenovirus-mediated ldl receptor gene transfer and targeting
DK0693924T4 (da) * 1993-02-22 2008-08-04 Abraxis Bioscience Inc Fremgangsmåde til (in vivo) levering af biologiske materialer og sammensætninger, der er egnede dertil
CA2171303C (en) * 1993-09-09 2006-06-06 Werner Weitschies Active principles and gas containing microparticles
US6048903A (en) * 1994-05-03 2000-04-11 Robert Toppo Treatment for blood cholesterol with trans-resveratrol
US5558092A (en) * 1995-06-06 1996-09-24 Imarx Pharmaceutical Corp. Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously
US6139819A (en) * 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US6265387B1 (en) * 1995-10-11 2001-07-24 Mirus, Inc. Process of delivering naked DNA into a hepatocyte via bile duct
US20010009904A1 (en) * 1997-12-30 2001-07-26 Jon A. Wolff Process of delivering a polynucleotide to a cell via the vascular system
US5849727A (en) * 1996-06-28 1998-12-15 Board Of Regents Of The University Of Nebraska Compositions and methods for altering the biodistribution of biological agents
DE69738640T2 (de) 1996-08-15 2009-07-16 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Räumliche und temporäre kontrolle der genexpression mittels eines hitzeschockproteinpromotors in kombination mit lokaler hitze
EP0949932A1 (de) * 1996-10-19 1999-10-20 Quadrant Healthcare (UK) Limited Verwendung von mikrokohlkugeln zur diagnose und therapie
US6120751A (en) * 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6575956B1 (en) 1997-12-31 2003-06-10 Pharmasonics, Inc. Methods and apparatus for uniform transcutaneous therapeutic ultrasound
US6066123A (en) * 1998-04-09 2000-05-23 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of bioavailability by use of focused energy delivery to a target tissue
US6135976A (en) * 1998-09-25 2000-10-24 Ekos Corporation Method, device and kit for performing gene therapy
WO2000042988A1 (en) 1999-01-21 2000-07-27 University Of Virginia Method of identifying and treating inflamed tissue
DE60026313D1 (de) * 1999-07-23 2006-04-27 Uutech Ltd Sensibilisierung von roten blutkörperchen gegenüber ultraschall durch einwirkung eines elektrischen feldes
IES990763A2 (en) * 1999-09-09 2001-04-04 Comtor Ltd A Wrapping Method and Apparatus

Also Published As

Publication number Publication date
WO2003006608A3 (en) 2004-03-11
WO2003006608A2 (en) 2003-01-23
AU2002320348B2 (en) 2007-07-19
CA2452471C (en) 2010-06-29
CA2452471A1 (en) 2003-01-23
JP2005500327A (ja) 2005-01-06
EP1420643A2 (de) 2004-05-26
AU2002320348B8 (en) 2003-01-29
US20040248832A1 (en) 2004-12-09
ATE392812T1 (de) 2008-05-15
JP4426288B2 (ja) 2010-03-03
US20070196283A1 (en) 2007-08-23
EP1420643B1 (de) 2008-04-23
US7211248B2 (en) 2007-05-01
DE60226251T2 (de) 2009-05-14
EP1420643A4 (de) 2005-01-05

Similar Documents

Publication Publication Date Title
ES2132644T3 (es) Metodo para reproducir in vitro la actividad proteolitica de la proteasa ns3 del virus de la hepatitis c (vhc).
ATE234638T1 (de) Gas-mischungen verwendbar als ultraschallkontrastmittel
DE60226251D1 (de) Verbesserung der transfektion von dna in die leber
EA200301278A1 (ru) Способ получения сложного полиэфира в присутствии диоксида титана с нанесенным покрытием
AR038026A1 (es) Gel que comprende al menos un retinoide y peroxido de benzoilo
IT1317951B1 (it) Leghe getter non evaporabili
DE69734605D1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
DE69837393D1 (de) Stimulierung von hämatopoietischen zellen im vitro
HUP0105052A2 (hu) Eljárások nukleinsav amplifikálására és szekvenálására
NO963617L (no) Gassfylte mikrokapsler til bruk som kontrastmidler
DE50016060D1 (de) Eisenoxid- und Siliciumdioxid-Titandioxid-Mischung
ATE492638T1 (de) Vektorkonstruktionen
ATE412755T1 (de) GENKONSTRUKT DAS FÜR EIN HETEROLOGES ßPRODRUGß- AKTIVIERENDES ENZYM UND FÜR EIN ZELLGERICHTES TEIL KODIERT
ATE437951T1 (de) Intrazelluläre herstellung von verkürztem hepatitis c-polypeptid e2
DE60108661D1 (de) Herstellung und verwendung von dendritischen zellen
ES2249058T3 (es) Factores de preservacion de celulas progenitoras y metodos y productos relacionados.
DE60137835D1 (de) Modifizierte zytokine für krebs therapie
DE69612993D1 (de) Verbesserte zusammensetzung mit pseudokatalase
FR2866248B1 (fr) Composition a base d'or et d'un oxyde reductible, procede de preparation et utilisation comme catalyseur, notamment pour l'oxydation du monoxyde de carbone
DE69737691D1 (de) Impfstoff, der peroxiredoxin enthält
MXPA03004539A (es) Luciferasas aisladas y uso de las mismas.
DE60030621D1 (de) DNA-Konstrukt zur gewebespezifischen Expression eines Blutkgerinnungsfaktors
MY128030A (en) Zirconia catalysts supports for nitrous oxide abatement
ATE310604T1 (de) Verwendung eines prozessgasgemisches zum laserstrahlschweissen
AR038849A1 (es) Uso de ribozimas en la deteccion de agentes adventicios

Legal Events

Date Code Title Description
8364 No opposition during term of opposition